Ukr.Biochem.J. 2016; Volume 88, Issue 1, Jan-Feb, pp. 119-125

doi: https://doi.org/10.15407/ubj88.01.119

Transcriptional regulation of NOX genes expression in human breast adenocarcinoma MCF-7 cells is modulated by adaptor protein Ruk/CIN85

02.03.2016   Uncategorized   No comments

A. V. Bazalii, I. R. Horak, G. V. Pasichnyk, S. V. Komisarenko, L. B. Drobot

Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv;
e-mail: drobot@biochem.kiev.ua

NADPH oxidases are key components of redox-dependent signaling networks involved in the control of cancer cell proliferation, survival and invasion. The data have been accumulated that demonstrate specific expression patterns and levels of NADPH oxidase homologues (NOXs) and accessory genes in human cancer cell lines and primary tumors as well as modulation of these parameters by extracellular cues. Our previous studies revealed that ROS production by human colorectal adenocarcinoma HT-29 cells is positively correla­ted with adaptor protein Ruk/CIN85 expression while increased levels of Ruk/CIN85 in weakly invasive human breast adenocarcinoma MCF-7 cells contribute to their malignant phenotype through the constitutive activation of Src/Akt pathway. In this study, to investigate whether overexpression of Ruk/CIN85 in MCF-7 cells can influence transcriptional regulation of NOXs genes, the subclones of MCF-7 cells with different levels­ of Ruk/CIN85 were screened for NOX1, NOX2, NOX3, NOX4, NOX5, DUOX1 and DUOX2 as well as for regulatory subunit p22Phox mRNA contents by quantitative RT-PCR (qPCR). Systemic multidirectional changes in mRNA levels for NOX1, NOX2, NOX5, DUOX2 and p22Phox were revealed in Ruk/CIN85 overexpressing cells in comparison to control WT cells. Knocking down of Ruk/CIN85 using technology of RNA-interference resulted in the reversion of these changes. Further studies are necessary to elucidate, by which molecular mechanisms Ruk/CIN85 could affect transcriptional regulation of NOXs genes.

Keywords: , , , ,

References:

  1. Weyemi U, Redon CE, Parekh PR, Dupuy C, Bonner WM. NADPH Oxidases NOXs and DUOXs as putative targets for cancer therapy. Anticancer Agents Med Chem. 2013 Mar;13(3):502-14. Review. PubMed
  2. Meitzler JL, Antony S, Wu Y, Juhasz A, Liu H, Jiang G, Lu J, Roy K, Doroshow JH. NADPH oxidases: a perspective on reactive oxygen species production in tumor biology. Antioxid Redox Signal. 2014 Jun 10;20(17):2873-89. Review. PubMed, PubMedCentral, CrossRef
  3. Roy K, Wu Y, Meitzler JL, Juhasz A, Liu H, Jiang G, Lu J, Antony S, Doroshow JH. NADPH oxidases and cancer. Clin Sci (Lond). 2015 Jun;128(12):863-75. Review. PubMed, CrossRef
  4. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol. 2004 Mar;4(3):181-9. Review. PubMed
  5. Katsuyama M. NOX/NADPH oxidase, the superoxide-generating enzyme: its transcriptional regulation and physiological roles. J Pharmacol Sci. 2010;114(2):134-46. Review. PubMed
  6. Finkel T. Reactive oxygen species and signal transduction. IUBMB Life. 2001 Jul;52(1-2):3-6. Review. PubMed
  7. Drobot LB, Samoylenko AA, Vorotnikov AV, Tyurin-Kuzmin PA, Bazalii AV, Kietzmann T, Tkachuk VA, Komisarenko SV. Reactive oxygen species in signal transduction. Ukr Biokhim Zhurn. 2013; 85: 209-217. CrossRef
  8. Juhasz A, Ge Y, Markel S, Chiu A, Matsumoto L, van Balgooy J, Roy K, Doroshow JH. Expression of NADPH oxidase homologues and accessory genes in human cancer cell lines, tumours and adjacent normal tissues. Free Radic Res. 2009 Jun;43(6):523-32. PubMed, PubMedCentral, CrossRef
  9. Pawson T. Dynamic control of signaling by modular adaptor proteins. Curr Opin Cell Biol. 2007 Apr;19(2):112-6. Review. PubMed
  10. Levchenko A, Bruck J, Sternberg PW. Scaffold proteins may biphasically affect the levels of mitogen-activated protein kinase signaling and reduce its threshold properties. Proc Natl Acad Sci USA. 2000 May 23;97(11):5818-23. PubMed, PubMedCentral
  11. Dikic I. CIN85/CMS family of adaptor molecules. FEBS Lett. 2002 Oct 2;529(1):110-5. Review. PubMed
  12. Havrylov S, Redowicz MJ, Buchman VL. Emerging roles of Ruk/CIN85 in vesicle-mediated transport, adhesion, migration and malignancy. Traffic. 2010 Jun;11(6):721-31. Review. PubMed, CrossRef
  13. Havrylov S, Rzhepetskyy Y, Malinowska A, Drobot L, Redowicz MJ. Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. Proteome Sci. 2009 Jun 16;7:21. PubMed, PubMedCentral, CrossRef
  14. Bazalii AV, Samoylenko AA, Petukhov DM, Rynditch AV, Redowicz M-J, Drobot LB. Interaction between adaptor proteins Ruk/CIN85 and Tks4 in normal and tumor cells of different tissue origins. Biopolym Cell. 2014; 30(1):37-41. CrossRef
  15. Gianni D, Diaz B, Taulet N, Fowler B, Courtneidge SA, Bokoch GM. Novel p47(phox)-related organizers regulate localized NADPH oxidase 1 (Nox1) activity. Sci Signal. 2009 Sep 15;2(88):ra54. PubMed, PubMedCentral, CrossRef
  16. Gianni D, DerMardirossian C, Bokoch GM. Direct interaction between Tks proteins and the N-terminal proline-rich region (PRR) of NoxA1 mediates Nox1-dependent ROS generation. Eur J Cell Biol. 2011 Feb-Mar;90(2-3):164-71. PubMed, PubMedCentral, CrossRef
  17. Samoylenko AA, Byts NV, Pasichnyk GV, Kozlova NV, Bazalii AV, Gerashchenko DS, Shandrenko SG, Vorotnikov AV, Kietzmann T, Komisarenko SV, Drobot LB. Recombinant lentivirus-mediated silencing of adaptor protein Ruk/CIN85 expression influences biological responses of tumor cells. Biotechnologia Acta. 2015; 8(4): 182-189. CrossRef
  18. Bazalii АV, Vorotnikov AV, Тiurin-Кuzmin PA, Тkachuk VА, Коmisarenko SV, Drobot LB. Recombinant fluorescent sensor of hydrogen peroxide hyper fused with adaptor protein Ruk/CIN85: designing of expression vector and its functional characterization. Biotechnologia Acta. 2015;8(5):19-26. CrossRef
  19. Samoylenko A, Vynnytska-Myronovska B, Byts N, Kozlova N, Basaraba O, Pasichnyk G, Palyvoda K, Bobak Y, Barska M, Mayevska O, Rzhepetsky Y, Shuvayeva H, Lyzogubov V, Usenko V, Savran V, Volodko N, Buchman V, Kietzmann T, Drobot L. Increased levels of the HER1 adaptor protein Rukl/CIN85 contribute to breast cancer malignancy. Carcinogenesis. 2012 Oct;33(10):1976-84. PubMed, CrossRef
  20. Pasichnyk GV, Povorozniuk OО, Horak IR, Gerashchenko DS, Ponomarenko OV, Samoylenko AA, Byts NV, Drobot LB. Overexpression of adaptor protein Rukl. CIN85 in human breast adenocarcinoma cell line MCF-7 is accompanied by increased chemoresistance. Reports Nat Acad Sci Ukraine. 2013;12:149-156.
  21. Samoylenko A, Dimova EY, Kozlova N, Drobot L, Kietzmann T. The adaptor protein Ruk/CIN85 activates plasminogen activator inhibitor-1 (PAI-1) expression via hypoxia-inducible factor-1alpha. Thromb Haemost. 2010 May;103(5):901-9. PubMed, CrossRef
  22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001 Dec;25(4):402-8.
    PubMed
  23. Fukuyama M, Rokutan K, Sano T, Miyake H, Shimada M, Tashiro S. Overexpression of a novel superoxide-producing enzyme, NADPH oxidase 1, in adenoma and well differentiated adenocarcinoma of the human colon. Cancer Lett. 2005 Apr 18;221(1):97-104. PubMed
  24. Kolářová H, Binó L, Pejchalová K, Kubala L. The expression of NADPH oxidases and production of reactive oxygen species by human lung adenocarcinoma epithelial cell line A549. Folia Biol (Praha). 2010;56(5):211-7. PubMed
Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.